Sucampo Pharmaceuticals, Inc. and Takeda Company Profile
Sucampo Pharmaceuticals, Inc., an international pharmaceutical company, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids, was first identified by Ryuji Ueno, M.D., Ph.D., Ph.D., Sucampo Pharmaceuticals' Chairman and Chief Executive Officer. Dr. Ueno founded Sucampo Pharmaceuticals in 1996 with Sachiko Kuno, Ph.D., founding Chief Executive Officer and currently Advisor, International Business Development, and a member of the Board of Directors. For more information, please visit www.sucampo.com.
News Articles
FDA expedites review of Sucampo-Takeda constipation drug Amitiza
The FDA gave Sucampo Pharmaceuticals and Takeda Pharmaceuticals USA's Amitiza, or lubiprostone, priority-review designation -More-
Sucampo falls on Amitiza arbitration decision
Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP) fell $1.72 (25%) to $5.23 on Friday after it said the International Chamber of Commerce (ICC) issued a final binding decision disagreeing with the company's...
Sucampo/Takeda drug Amitiza wins 1st FDA nod in OIC non-cancer pain
Sucampo Pharmaceuticals and its partner Takeda won the US FDA's blessing on 23 April to market Amitiza (lubiprostone) 24mcg twice daily as the first and only oral medicine to treat opioid-induced c...
U.K. approves Sucampo's Amitiza
The U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) approved twice-daily Amitiza lubiprostone from Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP) to treat chronic idiopathic constipation...
Sucampo seeks Takeda talks after losing legal battle
(Reuters) - U.S. drugmaker Sucampo Pharmaceuticals is seeking talks with marketing partner Takeda Pharmaceutical Co Ltd to mend their relationship, after losing a two-year legal battle to sever ties w...
US FDA awards priority review for Sucampo/Takeda constipation drug
Sucampo and Takeda won a six-month priority review for their supplemental new drug application (sNDA) for Amitiza (lubiprostone) as a treatment for opioid-induced constipation (OIC) in patients with...
Sucampo fails in Amitiza arbitration with Takeda
US drugmaker Sucampo Pharmaceuticals (Nasdaq: SCMP) says that it has received a final binding decision on its claims in the dispute with its partner, Japan's biggest drugmaker Takeda Pharmaceutical (T...
Sucampo Pharmaceuticals Announces Arbitration Decision
BETHESDA, Md.--(BUSINESS WIRE)--Jul 6, 2012 - Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that it has received a final binding decision on its claims in the dispute with its partner,...
Drugs and Medications
Prevacid [Novartis Consumer Health, Inc.]
PREVACID 24 HRLansoprazole delayed-release capsules 15mg / acid reducer
Lupron depot ped [Takeda Pharmaceutical Company LTD]
LUPRON DEPOT-PED (leuprolide acetate for depot suspension) 7.5 mg, 11.25 mg and 15 mg
Edarbi [Takeda Pharmaceuticals America, Inc.]
These HIGHLIGHTS do not include all the information needed to use EDARBI safely and effectively. See full prescribing information for EDARBI. Edarbi (azilsartan medoxomil) tabletsInitial U.S. Approval...
Actos [Takeda Pharmaceutical Co LTD]
ACTOS (pioglitazone hydrochloride) Tablets
Actos [Rebel Distributors Corp.]
ACTOS (pioglitazone hydrochloride) Tablets
PubMed Articles
Pioglitazone and risk of bladder cancer: clarification of the design of the French study.
Long-term response to maintenance treatment with rituximab in CD20(+) multiple myeloma.
Structure-based discovery of cellular-active allosteric inhibitors of FAK.
In order to develop potent and selective focal adhesion kinase (FAK) inhibitors, synthetic studies on pyrazolo[4,3-c][2,1]benzothiazines targeted for the FAK allosteric site were carried out. Based on...
Numerous aggregates of "tiny" micromegakaryocytes in the bone marrow.
Clinical Trials
Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg
The objective of this study was to investigate the bioequivalence of Mylan pioglitazone HCl 45 mg tablets to Takeda Actos® 45 mg tablets following a single, oral 45 mg (1 x 45 mg) dose ad...
Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg
The objective of this study was to investigate the bioequivalence of Mylan pioglitazone HCl 45 mg tablets to Takeda Actos® 45 mg tablets following a single, oral 45 mg (1 x 45 mg) dose ad...
Companies
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc.
Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs based on proston...
Sucampo Pharmaceuticals, Inc. and Takeda
Sucampo Pharmaceuticals, Inc., an international pharmaceutical company, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The...
Sucampo Pharmaceuticals, Inc. and Numab AG
Sucampo Pharmaceuticals, Inc., an international pharmaceutical company based in Bethesda, Maryland, is focused on the discovery, development and commercialization of proprietary d...
Sucampo Pharmaceuticals, Inc. and Abbott
Sucampo Pharmaceuticals, Inc., an international biopharmaceutical company based in Bethesda, Maryland, focuses on the development and commercialization of medicines based on prost...
Takeda San Francisco, Inc. (TSF), established in November 2007 as a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Osaka, Japan, is Takeda's Biologics Center of Excellence and Antib...
More Information about "Sucampo Pharmaceuticals, Inc. and Takeda" on BioPortfolio
We have published hundreds of Sucampo Pharmaceuticals, Inc. and Takeda news stories on BioPortfolio along with dozens of Sucampo Pharmaceuticals, Inc. and Takeda Clinical Trials and PubMed Articles about Sucampo Pharmaceuticals, Inc. and Takeda for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sucampo Pharmaceuticals, Inc. and Takeda Companies in our database. You can also find out about relevant Sucampo Pharmaceuticals, Inc. and Takeda Drugs and Medications on this site too.
